Information: Detta är inte den senaste versionen av datamodellen. Du hittar en versionsöversikt till vänster under versioner. Den senaste versionen hittar du här.
Information:
Fel:
ID
13016
Beskrivning
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible (PAZOPANIB-AML) https://clinicaltrials.gov/ct2/show/NCT01361334 Principal Investigator: PD Dr. Torsten Kessler, University Hospital Muenster, Germany
Länk
https://clinicaltrials.gov/ct2/show/NCT01361334
Nyckelord
Versioner (3)
- 2015-08-14 2015-08-14 - Martin Dugas
- 2016-01-12 2016-01-12 -
- 2016-02-11 2016-02-11 -
Uppladdad den
12 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Concomitant Medication AML Pazopanib NCT01361334
Concomitant Medication AML Pazopanib NCT01361334
- StudyEvent: SE
Similar models
Concomitant Medication AML Pazopanib NCT01361334
- StudyEvent: SE
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Item
Visit info/Therapeutic regimen timepoint
text
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,2])
CL Item
Baseline (1)
CL Item
Tag 1 (2)
CL Item
Tag 2 (3)
CL Item
Tag 7 (4)
CL Item
Tag 10 (5)
CL Item
Tag 14 (6)
CL Item
Tag 28 (7)
CL Item
Monat 2 (8)
CL Item
Monat 3 (9)
CL Item
Monat 6 (10)
CL Item
Monat 9 (11)
CL Item
Monat 12 (12)
CL Item
Progression - Rezidiv (13)
CL Item
Follow Up - Blatt Nr. 1 (14)
CL Item
Follow Up - Blatt Nr. 2 (15)
CL Item
Follow Up - Blatt Nr. 3 (16)
CL Item
Follow Up - Blatt Nr. 4 (17)
CL Item
Clarithromycin (1)
CL Item
Telithromycin (1)
CL Item
Troleandomycin (1)
CL Item
Itraconazol (1)
CL Item
Ketoconazol (1)
CL Item
Voriconazol (1)
CL Item
Fluconazol (1)
Item
HIV-Protease-Inhibitors: Ritonavir
text
C0292818 (UMLS CUI [1])
CL Item
Ritonavir (1)
Item
HIV-Protease-Inhibitors: Indinavir
text
C0376637 (UMLS CUI [1])
CL Item
Indinavir (1)
Item
HIV-Protease-Inhibitors: Saquinavir
text
C0286738 (UMLS CUI [1])
CL Item
Saquinavir (1)
Item
HIV-Protease-Inhibitors: Nelfinavir
text
C0525005 (UMLS CUI [1])
CL Item
Nelfinavir (1)
Item
HIV-Protease-Inhibitors: Amprenavir
text
C0754188 (UMLS CUI [1])
CL Item
Amprenavir (1)
Item
HIV-Protease-Inhibitors: Lopinavir
text
C0674432 (UMLS CUI [1])
CL Item
Lopinavir (1)
CL Item
Nefazodon (1)
CL Item
Grapefruitsaft (1)
CL Item
weitere (9)
Sonstige 1: Weitere - Text
Item
Other 1: description text
text
C0205394 (UMLS CUI [1])
Item
Anticoagulants: Phenprocoumon (Marcumar)
text
C0031444 (UMLS CUI [1])
CL Item
Phenprocoumon (Marcumar) (1)
Item
Anticoagulants: Heparin (NMH/UFH)
text
C0019134 (UMLS CUI [1])
CL Item
Heparin (NMH/UFH) (1)
CL Item
Ticagrelor (1)
CL Item
ASS (1)
CL Item
other (1)
CL Item
Beta-Antagonists (1)
Item
Antihypertensives: Calcium channel blockers
text
C0006684 (UMLS CUI [1])
CL Item
Kalziumantagonisten (1)
CL Item
ACE-Inhibitors (1)
Item
Antihypertensives: Angiotensin-II-Antagonists
text
C0521942 (UMLS CUI [1])
Code List
Antihypertensives: Angiotensin-II-Antagonists
CL Item
Angiotensin-II-Antagonists (1)
CL Item
Diuretics (1)
Item
Antihypertensives: other
text
C0003364 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
CL Item
other (9)
CL Item
Penicilline (1)
CL Item
Cephalosporine (1)
CL Item
Carbapenemes (1)
CL Item
Aminogylcosides (1)
CL Item
Tetracyclines (1)
CL Item
Lincosamines (1)
Item
Antibiotics 2: other
text
C0003232 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
CL Item
other (9)
Item
Antiarrhythmics: Class I antiarrhythmic drug
text
C0360692 (UMLS CUI [1])
Code List
Antiarrhythmics: Class I antiarrhythmic drug
CL Item
Class I antiarrhythmic drug (1)
Item
Antiarrhythmics: Class II antiarrhythmic drug
text
C0360701 (UMLS CUI [1])
CL Item
Class II antiarrhythmic drug (1)
Item
Antiarrhythmics: Class III antiarrhythmic drug
text
C0360703 (UMLS CUI [1])
Code List
Antiarrhythmics: Class III antiarrhythmic drug
CL Item
Class III antiarrhythmic drug (1)
Item
Antiarrhythmics: Class IV antiarrhythmic drug
text
C0360706 (UMLS CUI [1])
Code List
Antiarrhythmics: Class IV antiarrhythmic drug
CL Item
Class IV antiarrhythmic drug (1)
Item
Antiarrhythmics: other
text
C0003195 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
CL Item
other (9)
CL Item
Glucocorticoids (1)
Item
Other 2: Proton Pump Inhibitors
text
C0358591 (UMLS CUI [1])
CL Item
Proton Pump Inhibitors (1)
CL Item
other (9)
Sonstige 2: Weitere - Text
Item
Other 2: other- text
text
Begleitmedikation: Signatur - Datum
Item
Concomitant medication - Signature date
date
C0807937 (UMLS CUI [1])
Item
Concomitant medication - Signature date status
text
C0807937 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0449438 (UMLS CUI [1,2])
CL Item
T (1)
CL Item
TM (2)
CL Item
M (3)
Item
Concomitant medication: Signature of investigator
text
C2346576 (UMLS CUI [1])
CL Item
yes (1)
CL Item
no (0)
Kommentar Begleitmedikation
Item
Comment Concomitant medication
text
C0947611 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])